Skip to Content

Tag: Barclays Capital


Also Noted

Trinity Biotech zeroes in on CGM 

March 13, 2025HME News Staff

DUBLIN – Trinity Biotech, a commercial-stage biotech company focused on human diagnostics and diabetes management solutions, including wearable biosensors, has appointed Barclays Capital as its exclusive financial advisor to support its ongoing strategic realignment, including its increased focus on continuous glucose monitoring technology. As part of this effort, Barclays is now actively assessing how the company’s existing businesses can best align with this new strategic direction....

Barclays Capital, Continuous Glucose Monitor (CGM), realignment, Trinity Biotech


Read Full Articlered right arrow icon